Economic assessment of capecitabine/cisplatin versus 5-FU/cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain

被引：0
|
作者：
Safont, M.
Darba, J.
Restovic, G.
Sastre, J.
Bellmunt Molins, J.
Gomez, M. A.
Salgado, M.
Vila, C.
Ramirez De Arellano, A.
机构：
[1] Univ Valencia, Gen Hosp, Valencia, Spain
[2] Univ Barcelona, Barcelona, Spain
[3] BCN Hlth Econ & Outcomes Res, Barcelona, Spain
[4] Hosp Clin San Carlos, Madrid, Spain
[5] Hosp del Mar, Barcelona, Spain
[6] Hosp Univ Reina Sofia, Madrid, Spain
[7] CH Orense, Orense, Spain
[8] Roche Pharma, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15549
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC):: a randomised phase III trial
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Philco, M.
    Suarez, T.
    Santamaria, J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 259 - 259
  • [32] A pilot trial of 5-FU, leucovorin, and cisplatin with or without Adriamycin in advanced cancer
    Vaughn, DJ
    Meropol, NJ
    Armstead, B
    Haller, DG
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 241 - 244
  • [33] A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
    Ducreux, M
    Rougier, P
    Pignon, JP
    Douillard, JY
    Seitz, JF
    Bugat, R
    Bosset, JF
    Merouche, Y
    Raoul, JL
    Ychou, M
    Adenis, A
    Berthault-Cvitkovic, F
    Luboinski, M
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (08) : 1185 - 1191
  • [34] Efficacy and feasibility of paclitaxel and cisplatin combination chemotherapy for the treatment of 5-flurouracil (5-FU), doxorubicin refractory advanced gastric cancer
    Kim, Y.
    Prrk, B.
    Seo, J.
    Gang, J.
    Lee, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Neoadjuvant and adjuvant radiochemotherapy of pancreatic cancer with 5-FU, cisplatin and interferon-alpha
    Schmidberger, H
    Horstmann, O
    Nitsche, M
    Hermann, R
    Becker, H
    Hess, CF
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 28 - 28
  • [36] New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin
    Mahlberg, Rolf
    Lorenzen, Sylvie
    Thuss-Patience, Peter
    Heinemann, Volker
    Pfeiffer, Per
    Mohler, Markus
    [J]. CHEMOTHERAPY, 2017, 62 (01): : 62 - 70
  • [37] Docetaxel and 5-FU continuous infusion (DF) versus epirubicin, cisplatin and 5-FU (ECF) for advanced gastric adenocarcinoma:: A randomised phase II study.
    Thuss-Patience, PC
    Kretzschmar, A
    Vielhaber, A
    Dörken, B
    Reichardt, P
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [38] Comparison of neoadjuvant Chemoradiotherapy with Docetaxel/Cisplatin/5-FU or Cisplatin alone in locally-advanced Oral cancer
    Abu Jawad, J.
    Grehl, S.
    Poettgen, C.
    Pfoertner, R.
    Eberhardt, W.
    Gauler, T.
    Arnold, G.
    Mohr, C.
    Stuschke, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 100 - 100
  • [39] CISPLATIN PLUS 5-FU FOR THE TREATMENT OF ADENOCARCINOMA OF THE COLON
    LOEHRER, PJ
    EINHORN, LH
    WILLIAMS, SD
    HUI, SL
    ESTES, NC
    PENNINGTON, K
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (12): : 1359 - 1363
  • [40] Capecitabine/cisplatin effective in advanced gastric cancer patients
    不详
    [J]. ONCOLOGY-NEW YORK, 2006, 20 (08): : 814 - +
12345